These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12626325)

  • 1. Skeletal muscle lipid metabolism with obesity.
    Hulver MW; Berggren JR; Cortright RN; Dudek RW; Thompson RP; Pories WJ; MacDonald KG; Cline GW; Shulman GI; Dohm GL; Houmard JA
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E741-7. PubMed ID: 12626325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
    Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.
    Cha BS; Ciaraldi TP; Park KS; Carter L; Mudaliar SR; Henry RR
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E151-9. PubMed ID: 15727952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.
    Holloway GP; Bezaire V; Heigenhauser GJ; Tandon NN; Glatz JF; Luiken JJ; Bonen A; Spriet LL
    J Physiol; 2006 Feb; 571(Pt 1):201-10. PubMed ID: 16357012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in skeletal muscle fatty acid binding protein (FABPC) content is directly related to weight loss and to changes in fat oxidation following a very low calorie diet.
    Blaak EE; Glatz JF; Saris WH
    Diabetologia; 2001 Nov; 44(11):2013-7. PubMed ID: 11719832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyl-CoA synthetase expression in human skeletal muscle is reduced in obesity and insulin resistance.
    Poppelreuther M; Lundsgaard AM; Mensberg P; Sjøberg K; Vilsbøll T; Kiens B; Füllekrug J
    Physiol Rep; 2023 Sep; 11(18):e15817. PubMed ID: 37726199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced incorporation of fatty acids into triacylglycerol in myotubes from obese individuals with type 2 diabetes.
    Sparks LM; Bosma M; Brouwers B; van de Weijer T; Bilet L; Schaart G; Moonen-Kornips E; Eichmann TO; Lass A; Hesselink MKC; Schrauwen P
    Diabetes; 2014 May; 63(5):1583-1593. PubMed ID: 24487026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.
    Bonen A; Parolin ML; Steinberg GR; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ; Dyck DJ
    FASEB J; 2004 Jul; 18(10):1144-6. PubMed ID: 15132977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.
    Blaak EE; Wagenmakers AJ; Glatz JF; Wolffenbuttel BH; Kemerink GJ; Langenberg CJ; Heidendal GA; Saris WH
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E146-54. PubMed ID: 10893334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein.
    Holloway GP; Perry CG; Thrush AB; Heigenhauser GJ; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1060-9. PubMed ID: 18349111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise.
    Berggren JR; Boyle KE; Chapman WH; Houmard JA
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E726-32. PubMed ID: 18252891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.
    Bruce CR; Anderson MJ; Carey AL; Newman DG; Bonen A; Kriketos AD; Cooney GJ; Hawley JA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5444-51. PubMed ID: 14602787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular lipid content is increased in obesity and decreased by weight loss.
    Goodpaster BH; Theriault R; Watkins SC; Kelley DE
    Metabolism; 2000 Apr; 49(4):467-72. PubMed ID: 10778870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans.
    Anastasiou CA; Kavouras SA; Lentzas Y; Gova A; Sidossis LS; Melidonis A
    Metabolism; 2009 Nov; 58(11):1636-42. PubMed ID: 19615699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolism, exercise and insulin action.
    Bonen A; Dohm GL; van Loon LJ
    Essays Biochem; 2006; 42():47-59. PubMed ID: 17144879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
    Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in Type II diabetic subjects.
    Schrauwen P; Schaart G; Saris WH; Slieker LJ; Glatz JF; Vidal H; Blaak EE
    Diabetologia; 2000 Nov; 43(11):1408-16. PubMed ID: 11126411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation.
    Smith BK; Jain SS; Rimbaud S; Dam A; Quadrilatero J; Ventura-Clapier R; Bonen A; Holloway GP
    Biochem J; 2011 Jul; 437(1):125-34. PubMed ID: 21463259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics.
    Chen MB; McAinch AJ; Macaulay SL; Castelli LA; O'brien PE; Dixon JB; Cameron-Smith D; Kemp BE; Steinberg GR
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3665-72. PubMed ID: 15769985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.